|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 182.42 USD | -1.06% |
|
+0.92% | -12.76% |
| 12-15 | BofA Securities Downgrades ICON to Neutral From Buy | MT |
| 12-09 | ICON plc Releases Findings from Two Biotech Sector Survey | CI |
Company Valuation: ICON Public Limited Company
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 10,290 | 25,209 | 15,860 | 23,304 | 17,314 | 14,078 | - | - |
| Change | - | 144.98% | -37.09% | 46.94% | -25.71% | -18.69% | - | - |
| Enterprise Value (EV) 1 | 9,797 | 29,891 | 20,223 | 26,700 | 20,201 | 17,100 | 16,599 | 15,522 |
| Change | - | 205.12% | -32.34% | 32.03% | -24.34% | -15.35% | -2.93% | -6.49% |
| P/E ratio | 31.7x | 138x | 31.7x | 38.3x | 22x | 28.5x | 19.2x | 17.6x |
| PBR | 5.56x | 3.13x | 1.87x | 2.53x | 1.78x | 1.51x | 1.37x | 1.25x |
| PEG | - | -2.2x | 0x | 1.8x | 0.8x | -0.9x | 0.4x | 1.94x |
| Capitalization / Revenue | 3.68x | 4.6x | 2.05x | 2.87x | 2.09x | 1.74x | 1.73x | 1.66x |
| EV / Revenue | 3.5x | 5.45x | 2.61x | 3.29x | 2.44x | 2.12x | 2.04x | 1.83x |
| EV / EBITDA | 20.6x | 30.8x | 13.7x | 15.8x | 11.6x | 10.8x | 10.6x | 9.35x |
| EV / EBIT | 23.9x | 45.6x | 14.7x | 17x | 12.6x | 12x | 12x | 10.6x |
| EV / FCF | 19x | 40.6x | 48x | 26.2x | 18.1x | 19x | 16.6x | 15.3x |
| FCF Yield | 5.28% | 2.46% | 2.08% | 3.82% | 5.54% | 5.28% | 6.02% | 6.55% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 6.15 | 2.25 | 6.13 | 7.4 | 9.53 | 6.459 | 9.583 | 10.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,797 | 5,481 | 7,741 | 8,120 | 8,282 | 8,076 | 8,126 | 8,502 |
| EBITDA 1 | 475.7 | 970 | 1,479 | 1,694 | 1,736 | 1,580 | 1,560 | 1,660 |
| EBIT 1 | 409.6 | 655 | 1,373 | 1,568 | 1,598 | 1,420 | 1,385 | 1,463 |
| Net income 1 | 332.3 | 153.2 | 505.3 | 612.3 | 791.5 | 556.4 | 726.4 | 836.2 |
| Net Debt 1 | -493.6 | 4,682 | 4,364 | 3,396 | 2,887 | 3,022 | 2,520 | 1,443 |
| Reference price 2 | 194.98 | 309.70 | 194.25 | 283.07 | 209.71 | 184.37 | 184.37 | 184.37 |
| Nbr of stocks (in thousands) | 52,775 | 81,398 | 81,645 | 82,327 | 82,559 | 76,360 | - | - |
| Announcement Date | 24/02/21 | 22/02/22 | 22/02/23 | 21/02/24 | 19/02/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 28.54x | 2.12x | 10.82x | -.--% | 14.08B | ||
| 36.62x | 5.32x | 17.81x | 0.94% | 46.18B | ||
| 31.48x | 3.18x | 13.71x | -.--% | 38.08B | ||
| 99.81x | 6.06x | 60.82x | -.--% | 34.38B | ||
| 52.75x | 10.17x | 28.77x | 0.39% | 27.99B | ||
| 37.77x | 6.11x | 27.77x | -.--% | 15.75B | ||
| -14.14x | 5519.7x | -13.33x | -.--% | 15.27B | ||
| -54.42x | 15.29x | -125.32x | -.--% | 13.03B | ||
| -35.51x | 13.39x | -38.25x | -.--% | 12.92B | ||
| -46.5x | 10.15x | 36168.69x | -.--% | 12.22B | ||
| Average | 13.64x | 559.15x | 3,615.15x | 0.13% | 22.99B | |
| Weighted average by Cap. | 29.76x | 373.12x | 1,932.89x | 0.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ICLR Stock
- Valuation ICON Public Limited Company
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















